ESC 365 - SS-AFRF - Shensong Yangxin capsule regulates persistent atrial fibrillation after RFCA

ESC Professional Premium Access

SS-AFRF - Shensong Yangxin capsule regulates persistent atrial fibrillation after RFCA

Session: Late-breaking science on atrial fibrillation

Topic: Rhythm Control, Antiarrhythmic Drugs

Speaker: Doctor H. Huang (Wuhan, CN)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor He Huang

Renmin Hospital of Wuhan University, Wuhan (China)

1 presentation

0 follower

3 more presentations in this session

SurHyb Trial: Hybrid Ablation in Persistent Atrial Fibrillation

Speaker: Professor A. Bulava (Ceske Budejovice, CZ)

CRALAL: Addtional right atrial ablation after cryoablation for AF

Speaker: Doctor D. Kim (Seoul, KR)

COMPARE CRYO - an RCT of PolarX vs. Arctic Front Cryo PVI with ICM endpoint assessment

Speaker: Professor T. Reichlin (Bern, CH)

Access the full session

Late-breaking science on atrial fibrillation

Speakers: Doctor H. Huang, Professor A. Bulava, Doctor D. Kim, Professor T. Reichlin

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources